Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 1. (+/-)-(3-pyridinylbicycloheptyl)alkanoic acids. | J Med Chem;34(6): 1790-7, 1991 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Thromboxane receptor antagonism combined with thromboxane synthase inhibition. 1. (+/-)-(3-pyridinylbicycloheptyl)alkanoic acids.

Bhagwat, S S; Gude, C; Cohen, D S; Lee, W; Furness, P; Clarke, F H.

Affiliation

Bhagwat SS; Research Department, CIBA-GEIGY Corporation, Summit, New Jersey 07901.

J Med Chem ; 34(6): 1790-7, 1991 Jun.

Article in En | MEDLINE | ID: mdl-1829485

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Thromboxane-A Synthase / Bridged Bicyclo Compounds / Receptors, Prostaglandin / Carboxylic Acids / Thromboxanes Limits: Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 1991 Document type: Article

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Thromboxane-A Synthase / Bridged Bicyclo Compounds / Receptors, Prostaglandin / Carboxylic Acids / Thromboxanes Limits: Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 1991 Document type: Article